Sensei Biotherapeutics Company
Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies.
Technology:
Small Molecules
Headquarters:
Gaithersburg, Maryland, United States
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Employee Number:
1-10
Industry:
PharmTech